Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
OtherClinical Investigations (Human)

Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake

Ian Alberts, Jan Niklas Huenermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Laeppchen, Eleni Gourni, Axel Rominger, Axel Rominger and Ali Afshar-Oromieh
Journal of Nuclear Medicine February 2021, jnumed.120.257741; DOI: https://doi.org/10.2967/jnumed.120.257741
Ian Alberts
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Niklas Huenermund
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christos Sachpekidis
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helle Damgaard Zacho
2 Aalborg University Hospital, Universitetshospital, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens Mingels
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lotte Dijkstra
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Peter Bohn
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tilman Laeppchen
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleni Gourni
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Rominger
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Rominger
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Afshar-Oromieh
1 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Purpose: Renal excretion of some prostate specific membrane antigen (PSMA)-ligands and consequently increased bladder activity can obscure locally relapsing prostate cancer (PC) lesions in PSMA-PET/CT. Furthermore, additional late imaging in PSMA-PET/CT provides a useful method to clarify uncertain findings. The aim of this retrospective study was to investigate a modified imaging protocol combining late additional imaging with hydration and forced diuresis in individuals undergoing additional late scanning for uncertain lesions or low PSA. Methods: We compared two protocols: one group of patients undergoing 68Ga-PSMA-11-PET/CT were examined at 90 min p.i. with 1L oral hydration beginning at 30min p.i. and 20mg of Furosemide i.v. at 1h p.i. followed by additional late imaging at 2.5h p.i. without further preparation (“old” protocol). A second group received the same procedure as before, with an additional 0.5L oral hydration and 10mg of Furosemide i.v. 30min before the late imaging. 132 patients (76 “old” protocol, 56 “new” protocol) were examined with respect to urinary bladder activity (SUVmean), PC-lesion uptake (SUVmax) and lesion contrast (tumor-SUVmax÷bladder-SUVmean for local relapses and tumor-SUVmax÷gluteal-musculature-SUVmean for non-local PC lesions). Results: Bladder activity was significantly greater for the “old” protocol in the late scans compared to the “new” protocol (ratio of bladder activity (2.5h÷1.5h): 2.33±1.17 vs. 1.37±0.50, p<0.0001). Increased tumor SUVmax and contrast was seen at 2.5h compared to 1.5h (p<0.0001 “old”; P = 0.02 “new”). Increased bladder activity for the “old” protocol resulted in decreased lesion-to-bladder contrast, which was not the case for the “new” protocol. Tumor-to-background ratios increased at late imaging for both protocols, but the increase was significantly lower for the “new” protocol. For the “old” protocol, comparing the 1.5h to 2.5h acquisitions, 4 lesions in 4 patients (4/76=5.2% of the cohort) were visible at the post-diuresis 1.5h acquisition, but not visible at 2.5h, having been obscured as a result of the higher bladder activity. In the new protocol, 2/56 (3.6%) of patients had lesions visible only at late imaging and two had lesions which could be better discriminated at late imaging. Conclusion: Although the combination of diuretics and hydration can be a useful method to increase the visualisation and detectability of locally recurrent PC in standard [68Ga]Ga-PSMA-11-PET/CT, their effects do not sufficiently continue into additional late imaging. Additional diuresis and hydration is recommended to improve visibility, detection and diagnostic certainty of local recurrences.

  • Oncology: GU
  • PET/CT
  • Radiopharmaceuticals
  • Diuresis
  • Dual-time point
  • Furosemide
  • Hydration
  • PSMA
  • Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (3)
Journal of Nuclear Medicine
Vol. 62, Issue 3
March 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake
Ian Alberts, Jan Niklas Huenermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Laeppchen, Eleni Gourni, Axel Rominger, Axel Rominger, Ali Afshar-Oromieh
Journal of Nuclear Medicine Feb 2021, jnumed.120.257741; DOI: 10.2967/jnumed.120.257741

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake
Ian Alberts, Jan Niklas Huenermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Laeppchen, Eleni Gourni, Axel Rominger, Axel Rominger, Ali Afshar-Oromieh
Journal of Nuclear Medicine Feb 2021, jnumed.120.257741; DOI: 10.2967/jnumed.120.257741
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
  • 18F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with 18F-FDG PET/CT as reference standard
  • A Prospective Randomized, Double-blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-differentiated Neuroendocrine Tumors
Show more Clinical Investigations (Human)

Clinical (Oncology: GU)

  • Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
  • Diagnostic Value, Oncological Outcomes And Safety Profile Of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy For Prostate Cancer.
Show more Clinical (Oncology: GU)

Similar Articles

Keywords

  • Oncology: GU
  • PET/CT
  • radiopharmaceuticals
  • Diuresis
  • Dual-time point
  • Furosemide
  • Hydration
  • PSMA
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire